Document Detail

A comparative study of fluoxetine, moclobemide, and tianeptine in the treatment of posttraumatic stress disorder following an earthquake.
MedLine Citation:
PMID:  15964747     Owner:  NLM     Status:  MEDLINE    
PURPOSE: Although antidepressant drugs have been proven as an effective treatment for posttraumatic stress disorder (PTSD), there are few comparative studies of antidepressants that are acting on different neurotransmitters. The main aim of this study is to compare the efficacy of different class of antidepressant drugs on the PTSD. SUBJECTS/MATERIALS AND METHODS: In this open label study, the patients who met DSM-IV criteria for PTSD were randomly assigned to flexible doses of fluoxetine, moclobemide, or tianeptine. After the first assessment, consecutive assessments were performed at the end of weeks 2, 4, 8, and 12 using clinician administered PTSD scale (CAPS) and Clinical Global Impression of Severity (CGI-S). Changes in the total score of CAPS and sub-scale scores of symptom clusters (re-experience, avoidance, and hyperarousal) were the main output of efficacy. All statistics were based on intention-to-treat and last-observation-carried-forward (LOCF) principles. RESULTS: Thirty-eight patients were assigned to fluoxetine, 35 patients were assigned to moclobemide, and 30 patients were assigned to tianeptine group. Gender distributions and mean ages of the treatment groups were not significantly different. Drop-out rates due to an adverse events or unknown reasons were not significantly different among fluoxetine (18.4%), moclobemide (14.3%), and tianeptine (20.0%) groups. All three treatments has led to a significant improvement in PTSD severity assessed with CAPS total score (ANOVA P < 0.001). Similarly, total scores of re-experiencing, avoidance, and hyperarousal clusters that are subscales of CAPS were significantly reduced by all three treatments (with ANOVA all P values < 0.001). There was not significant difference in terms of treatment effect between three groups. DISCUSSION: Treatment groups showed very similar improvement on all ratings scales. The findings support that fluoxetine, moclobemide, and tianeptine are all effective in the treatment of PTSD. Different mechanisms of action for these antidepressant drugs might result in the same common neurochemical end point. However, further studies using different classes of antidepressant drugs are needed.
E Onder; U Tural; T Aker
Related Documents :
17632247 - Longitudinal study of posttraumatic stress disorder, depression, and changes in traumat...
22691007 - The role of emotional nonacceptance in the relation between depression and recent cigar...
19245387 - Posttraumatic stress disorder in migraine.
12630657 - Three- to four-year follow-up to an open trial of nefazodone for combat-related posttra...
20721827 - Ch-1504, a metabolically inert antifolate for the potential treatment of rheumatoid art...
19685947 - Frontolimbic activity and cognitive bias in major depression.
Publication Detail:
Type:  Comparative Study; Journal Article; Randomized Controlled Trial     Date:  2005-06-17
Journal Detail:
Title:  European psychiatry : the journal of the Association of European Psychiatrists     Volume:  21     ISSN:  0924-9338     ISO Abbreviation:  Eur. Psychiatry     Publication Date:  2006 Apr 
Date Detail:
Created Date:  2006-04-24     Completed Date:  2006-10-03     Revised Date:  2008-11-21    
Medline Journal Info:
Nlm Unique ID:  9111820     Medline TA:  Eur Psychiatry     Country:  France    
Other Details:
Languages:  eng     Pagination:  174-9     Citation Subset:  IM    
Center for Psychological Trauma, Medical School of Kocaeli University, Kocaeli, Turkey.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Analysis of Variance
Antidepressive Agents / adverse effects,  therapeutic use
Antidepressive Agents, Second-Generation / adverse effects,  therapeutic use
Antidepressive Agents, Tricyclic / adverse effects,  therapeutic use
Fluoxetine / adverse effects,  therapeutic use*
Moclobemide / adverse effects,  therapeutic use*
Psychiatric Status Rating Scales
Severity of Illness Index
Stress Disorders, Post-Traumatic / drug therapy*,  etiology,  psychology
Thiazepines / adverse effects,  therapeutic use*
Time Factors
Treatment Outcome
Reg. No./Substance:
0/Antidepressive Agents; 0/Antidepressive Agents, Second-Generation; 0/Antidepressive Agents, Tricyclic; 0/Thiazepines; 54910-89-3/Fluoxetine; 66981-73-5/tianeptine; 71320-77-9/Moclobemide

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  The use of atypical antipsychotics in the treatment of catatonia.
Next Document:  Change in perfusion, hallucinations and fluctuations in consciousness in dementia with Lewy bodies.